Lv44
640 积分 2023-07-18 加入
Potent and isoform-selective PARP1 degraders for the treatment of BRCA-deficient cancers
2天前
已完结
Targeted protein degradation of PDE4 shortforms by a novel proteolysis targeting chimera
9天前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
11天前
已关闭
Misconceptions among medicinal chemists regarding ADME and PK optimization
1个月前
已完结
文献求助
3个月前
已完结
Efficient One‐Pot Synthesis of Enantiomerically Pure 2‐(Hydroxymethyl)morpholines
5个月前
已完结
皖公网安备34019202002308
